PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS. GenApp. 2018;2(2):51-56. doi:10.31383/ga.vol2iss2pp51-56